Varanasi: In a broad study of consequences, Dr.
Samarendra Kumar Singh, assistant professor, biotechnology school, the Institute of Science, Bhu has found a non-invasive way to diagnose cervical cancer in patients.
This finding has been published in the prestigious journal, ‘Journal of Cancer Research and Therapeutics (JCRT)’.
This study reports cost-effective and specific methods for early detection, treatment monitoring, residual disease status and distant tumor metastasis in the cervix.
Cancer patients.
The study was conducted in collaboration with the Department of Radiotherapy and Radiation Medicine, the Medical Institute of Medicine, Bhu.Dr Singh said, “During the study, it was shown that the free DNA circulated cells could be used as an effective marker.
To evaluate the burden of tumors in patients, both in untreated individuals and treated.
This study also shows that during the loading of the CCFDNA Kemo-radiotherapy together disappears and after six months of follow-up reappear because of the remote metastasis.
The sensitivity and specificity of this method and the short half of the CCFDNA makes this method reliable Strong as biomarkers are affordable and real-time to detect the burden of tumors in patients with cervical carcinoma.
“This study also shows how to follow up on prognostic results.
Medicine / operation using blood samples from cancer patients.
He said this study at solving can be very useful in developing diagnostics to detect cervical cancer which is one of the killers of women around the world.
This study was conducted in patients who were confirmed by biopsy.
It should be noted that the only way to diagnose cervical cancer among patients is through a network biopsy, which is not only painful but also not available and can be accessed by everyone.
Finding alternative ways to diagnose cervical cancer can become a changemaker in terms of health care and care.
According to him, this research was conducted at one of the Laboratory of the Institute of Science, Bhu, who conducted research in the field of cancer, especially cervical cancer.
For this purpose, the lab uses various molecular biology, biochemistry and structural biological tools.
It tries to investigate why cell cycle behavior in the wrong cancer cell is set.